Veterans Formulary Advisory Committee

(a) Establishment The Secretary of Veterans Affairs shall establish an advisory committee, to be known as the Veterans Formulary Advisory Committee (in this section referred to as the Advisory Committee). The Advisory Committee shall provide veteran and clinician input on the national formulary of the Department of Veterans Affairs. (b) Membership The Advisory Committee shall consist of not more than ten members and shall include front-line clinical providers or pharmacists of the Department who are not involved in national formulary decision-making and other stakeholder representatives as the Secretary considers appropriate. (c) Meetings The Advisory Committee shall meet at regular intervals (at least semiannually) and shall review proposed formulary changes. (d) Responsibilities The Advisory Committee may provide to the Secretary and to the Pharmacy and Therapeutics Committee established under section 7386 of title 38, United States Code, the independent feedback or recommendations of the Advisory Committee regarding proposed additions, removals, and restrictions pertaining to the national formulary, including with respect to any potential effects on veteran patients. Recommendations of the Advisory Committee shall be advisory in nature. (e) Termination The Advisory Committee shall terminate on the date that is two years after the date of the establishment of the Advisory Committee.